Patent directory · USPTO A61K / A61P
Patents matching “Alnylam Pharmaceuticals, Inc.”
376 pharma patents match "Alnylam Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 376 pharmaceutical patents matching "Alnylam Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9574192
Serapina1 iRNA compositions and methods of use thereof
granted -
US 9566295
GNAQ targeted dsRNA compositions and methods for inhibiting expression
granted -
US 9566340
Monomers and oligonucleotides comprising cycloaddition adduct(s)
granted -
US 9506067
Compositions and methods for inhibiting expression of the HAMP gene
granted -
US 9463247
Branched alkyl and cycloalkyl terminated biodegradable lipids for the delivery of active agents
granted -
US 9453222
Ligand-conjugated monomers
granted -
US 9441225
Compositions and methods for inhibiting expression of factor V
granted -
US 9422562
Compositions and methods for inhibiting expression of CD274/PD-L1 gene
granted -
US 9415109
Stable non-aggregating nucleic acid lipid particle formulations
granted -
US 9399775
RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases
granted -
US 9394540
Modified iRNA agents
granted -
US 9376680
Serpinc1 iRNA compositions and methods of use thereof
granted -
US 9370582
Carbohydrate conjugates as delivery agents for oligonucleotides
granted -
US 9370581
Carbohydrate conjugates as delivery agents for oligonucleotides
granted -
US 9352048
Carbohydrate conjugates as delivery agents for oligonucleotides
granted -
US 9339513
Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes
granted -
US 9322018
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
granted -
US 9315813
Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes
granted -
US 9290760
Modified iRNA agents
granted -
US 9260718
Compositions and methods for inhibiting expression of the PCSK9 gene
granted -
US 9254327
Methods and compositions for delivery of active agents
granted -
US 9249415
Complement component C5 iRNA compositions and methods of use thereof
granted -
US 9234196
Compositions and methods for inhibiting expression of transthyretin
granted -
US 9228188
Compositions and method for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-related gene expression
granted